AVAX ONE (AVX) CFO adds shares through open-market buy and large grant

Rhea-AI Filing Summary

AVAX ONE TECHNOLOGY LTD. Chief Financial Officer Christopher Vincent Polimeni reported two recent changes in his personal holdings of the company's common shares. He made an open-market purchase of 2,500 common shares at $1.75 per share, increasing his directly owned stake. Earlier, he received a grant or award of 105,485 common shares at a stated price of $2.37 per share, which brought his direct ownership to 105,485 shares at that time. After the later market purchase, his directly held position rose to 107,985 common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Polimeni Christopher Vincent

(Last) (First) (Middle)

215 S. OLIVE AVE., STE 201

(Street)

WEST PALM BEACH, FL 33401

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVAX ONE TECHNOLOGY LTD. [ AVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares(1)	09/18/2025		A		105,485	A	$2.37	105,485	D
Common Shares	11/21/2025		P		2,500	A	$1.75	107,985	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Price on date of grant.

	/s/ Christopher Polimeni	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did AVAX ONE (AVX) CFO Christopher Polimeni report?

AVAX ONE CFO Christopher Polimeni reported an open-market purchase and a share grant. He bought 2,500 common shares at $1.75 per share and separately received a grant of 105,485 common shares at a stated price of $2.37 per share.

How many AVAX ONE (AVX) shares did the CFO buy in the open market?

The CFO purchased 2,500 AVAX ONE common shares in the open market. The transaction price was $1.75 per share, indicating a relatively small but direct increase in his personal investment in the company’s stock.

What share grant did the AVAX ONE (AVX) CFO receive according to the Form 4?

The Form 4 shows the CFO received a grant or award of 105,485 AVAX ONE common shares. The filing lists a price of $2.37 per share for this award, and a footnote explains this reflects the price on the date of grant.

What is the AVAX ONE (AVX) CFO’s direct share ownership after these transactions?

After the reported transactions, the CFO directly owns 107,985 AVAX ONE common shares. This total reflects his prior grant of 105,485 shares combined with his later open-market purchase of 2,500 additional shares disclosed in the filing.

Were the AVAX ONE (AVX) CFO’s Form 4 transactions classified as buys or awards?

The filing classifies one transaction as an open-market purchase and the other as a grant or award. The 2,500-share transaction is coded as a purchase, while the 105,485-share transaction is coded as a grant, award, or other acquisition.